Pediatric narcolepsy.
Peterson PC, Husain AM.
Brain Dev. 2008 Nov;30(10):609-23. doi: 10.1016/j.braindev.2008.02.004. Epub 2008 Mar 28.
[Hypnogogic hallucinations of macrosomatognosia and microsomatognosia].
Podoll K, Mühlbauer V, Houben I, Ebel H.
Fortschr Neurol Psychiatr. 1998 Aug;66(8):338-44. doi: 10.1055/s-2007-995271.
Excessive daytime sleepiness in cancer patients.
Jaumally BA, Das A, Cassell NC, Pachecho GN, Majid R, Bashoura L, Balachandran DD, Faiz SA.
Sleep Breath. 2021 Jun;25(2):1063-1067. doi: 10.1007/s11325-020-02151-9. Epub 2020 Sep 16.
Narcolepsy: pathogenesis and nursing care.
Bergstrom DL, Keller C.
J Neurosci Nurs. 1992 Jun;24(3):153-7. doi: 10.1097/01376517-199206000-00006.
Personality and reports of hallucination and imagery in a normal population.
Jakes S, Hemsley DR.
Percept Mot Skills. 1987 Jun;64(3 Pt 1):765-6. doi: 10.2466/pms.1987.64.3.765.
Quetiapine for hypnogogic musical release hallucinations.
David RR, Fernandez HH.
J Geriatr Psychiatry Neurol. 2000 Winter;13(4):210-1. doi: 10.1177/089198870001300406.
Etiopathogenesis and neurobiology of narcolepsy: a review.
Kumar S, Sagili H.
J Clin Diagn Res. 2014 Feb;8(2):190-5. doi: 10.7860/JCDR/2014/7295.4057. Epub 2013 Dec 27.
Narcolepsy in children: a diagnostic and management approach.
Babiker MO, Prasad M.
Pediatr Neurol. 2015 Jun;52(6):557-65. doi: 10.1016/j.pediatrneurol.2015.02.020. Epub 2015 Mar 2.
Effectiveness and safety of dual orexin receptor antagonists for the prevention of delirium: A systematic review with meta-analysis and trial sequential analysis.
Singh S, Mathur R, Chakladar A, Pal A.
Gen Hosp Psychiatry. 2026 Jan-Feb;98:73-83. doi: 10.1016/j.genhosppsych.2025.12.006. Epub 2025 Dec 12.
The neuropharmacology of sleep paralysis hallucinations: serotonin 2A activation and a novel therapeutic drug.
Jalal B.
Psychopharmacology (Berl). 2018 Nov;235(11):3083-3091. doi: 10.1007/s00213-018-5042-1. Epub 2018 Oct 5.
